All Stories

  1. The arsenic proteome in cancer: Unravelling molecular mechanisms of anticancer drugs
  2. 24th international Biometals webinars
  3. Bismuth drug as an antibiotic adjuvant to inhibit biofilm formation via a dual mechanism
  4. High-throughput bead-based cytokine profiling reveals dynamic immune signatures and identifies candidate exploratory biomarkers in CAR-T therapy
  5. Molecular Insights into Bismuth’s New Applications against Antimicrobial Resistance and Coronaviruses
  6. The metallome and the biological periodic table: A metal atlas in cells
  7. Au(I)-based compounds inhibit nsp14/nsp10 and nsp13 (helicase) to exert anti-SARS-CoV-2 properties
  8. Metal-modulated T cell antitumor immunity and emerging metalloimmunotherapy
  9. Metal-Based Approaches for the Fight against Antimicrobial Resistance: Mechanisms, Opportunities, and Challenges
  10. Hinokitiol potentiates antimicrobial activity of bismuth drugs: a combination therapy for overcoming antimicrobial resistance
  11. Bismuth drug eradicates multi-drug resistant Burkholderia cepacia complex via aerobic respiration
  12. Unprecedented allosteric inhibition of E. coli malate dehydrogenase by silver(i) from atomic resolution analysis
  13. Lighting Up and Identifying Metal-Binding Proteins in Cells
  14. Bismuth-based drugs sensitize Pseudomonas aeruginosa to multiple antibiotics by disrupting iron homeostasis
  15. Integration of metalloproteome and immunoproteome reveals a tight link of iron-related proteins with COVID-19 pathogenesis and immunity
  16. Protein-templated ligand discovery via the selection of DNA-encoded dynamic libraries
  17. Copper regulates the host innate immune response against bacterial infection via activation of ALPK1 kinase
  18. Clinically used drug arsenic trioxide targets XIAP and overcomes apoptosis resistance in an organoid-based preclinical cancer model
  19. Mechanistic insights into bismuth(iii) inhibition of SARS-CoV-2 helicase
  20. Metal-detection based techniques and their applications in metallobiology
  21. Introduction to “Chemical biology of metals”
  22. Development of Pan-Anti-SARS-CoV-2 Agents through Allosteric Inhibition of nsp14/nsp10 Complex
  23. SaeR as a novel target for antivirulence therapy against Staphylococcus aureus
  24. Metallo-sideromycin as a dual functional complex for combating antimicrobial resistance
  25. Metalloproteomics
  26. Mitochondrial ATP synthase as a direct molecular target of chromium(III) to ameliorate hyperglycaemia stress
  27. Rapid synthesis of bismuth-organic frameworks as selective antimicrobial materials against microbial biofilms
  28. Gold drugs as colistin adjuvants in the fight against MCR-1 producing bacteria
  29. A dual covalent binder for labelling and inhibiting serine and metallo-carbapenemases
  30. Dual-action gallium-flavonoid compounds for combating Pseudomonas aeruginosa infection
  31. Metallomics and metalloproteomics
  32. Metal-coding assisted serological multi-omics profiling deciphers the role of selenium in COVID-19 immunity
  33. Metal Complexes as Resistance Breakers or Metalloantibiotics for Combating Antimicrobial Resistance
  34. Computed Tomography of Cartilage: An Exploration of Novel Cationic Bismuth Contrast Agent
  35. Binding of ruthenium and osmium at non‑iron sites of transferrin accounts for their iron-independent cellular uptake
  36. An ensemble 3D deep-learning model to predict protein metal-binding site
  37. Metalloproteomics for Biomedical Research: Methodology and Applications
  38. Re-sensitization of mcr carrying multidrug resistant bacteria to colistin by silver
  39. Regulation of DNA-binding activity of the Staphylococcus aureus catabolite control protein A by copper (II)-mediated oxidation
  40. A hydroxide lock for metallo-β-lactamases
  41. Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy
  42. Multiplex metal-detection based assay (MMDA) for COVID-19 diagnosis and identification of disease severity biomarkers
  43. Metal-based strategies for the fight against COVID-19
  44. Multiplex Single‐Cell Analysis of Cancer Cells Enables Unbiased Uncovering Subsets Associated with Cancer Relapse: Heterogeneity of Multidrug Resistance in Precursor B‐ALL
  45. Eradication of Porphyromonas gingivalis Persisters Through Colloidal Bismuth Subcitrate Synergistically Combined With Metronidazole
  46. Author Correction: Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  47. Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance
  48. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2
  49. Medicinal chemistry and biomedical applications of bismuth-based compounds and nanoparticles
  50. A. Sigel, E. Freisinger & R. K. O. Sigel (Eds.), M. E. Sosa Torres & P. M. H. Kroneck (volume Eds.): Transition Metals and Sulfur – A Strong Relationship for Life
  51. Resensitizing carbapenem- and colistin-resistant bacteria to antibiotics using auranofin
  52. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
  53. Metalloproteomics in conjunction with other omics for uncovering the mechanism of action of metallodrugs: Mechanism-driven new therapy development
  54. Bismuth—The Magic Element
  55. Atomic differentiation of silver binding preference in protein targets:Escherichia colimalate dehydrogenase as a paradigm
  56. Bismuth drugs as antimicrobial agents
  57. Predicting disease-associated mutation of metal-binding sites in proteins using a deep learning approach
  58. Zinc excess increases cellular demand for iron and decreases tolerance to copper in Escherichia coli
  59. Recognition of Proteins by Metal Chelation-Based Fluorescent Probes in Cells
  60. Metalloproteomics for Unveiling the Mechanism of Action of Metallodrugs
  61. Deciphering molecular mechanism of silver by integrated omic approaches enables enhancing its antimicrobial efficacy in E. coli
  62. Bismuth drugs tackle Porphyromonas gingivalis and attune cytokine response in human cells
  63. The unique trimeric assembly of the virulence factor HtrA from Helicobacter pylori occurs via N-terminal domain swapping
  64. A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein
  65. Green Fluorescent Probe for Imaging His6-Tagged Proteins Inside Living Cells
  66. MetaMarker: a pipeline for de novo discovery of novel metagenomic biomarkers
  67. Antimicrobial silver targets glyceraldehyde-3-phosphate dehydrogenase in glycolysis of E. coli
  68. Bismuth: Environmental Pollution and Health Effects
  69. Combination of gallium(iii) with acetate for combating antibiotic resistant Pseudomonas aeruginosa
  70. S-Dimethylarsino-glutathione (darinaparsin®) targets histone H3.3, leading to TRAIL-induced apoptosis in leukemia cells
  71. Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori Infection
  72. Cell Cycle-Dependent Uptake and Cytotoxicity of Arsenic-Based Drugs in Single Leukemia Cells
  73. The role of citrate, lactate and transferrin in determining titanium release from surgical devices into human serum
  74. Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
  75. Metallochaperone UreG serves as a new target for design of urease inhibitor: A novel strategy for development of antimicrobials
  76. Multi-omics and temporal dynamics profiling reveal disruption of central metabolism inHelicobacter pylorion bismuth treatment
  77. Tracking iron-associated proteomes in pathogens by a fluorescence approach
  78. Functional disruption of peroxiredoxin by bismuth antiulcer drugs attenuates Helicobacter pylori survival
  79. A Ni-NTA-based red fluorescence probe for protein labelling in live cells
  80. Cytotoxicity of arsenic trioxide in single leukemia cells by time-resolved ICP-MS together with lanthanide tags
  81. Identification of catabolite control protein A fromStaphylococcus aureusas a target of silver ions
  82. Integration of fluorescence imaging with proteomics enables visualization and identification of metallo-proteomes in living cells
  83. Integrative approach for the analysis of the proteome-wide response to bismuth drugs in Helicobacter pylori
  84. Exploration into the nickel ‘microcosmos’ in prokaryotes
  85. UreE-UreG Complex Facilitates Nickel Transfer and Preactivates GTPase of UreG in Helicobacter pylori
  86. Glutathione and multidrug resistance protein transporter mediate a self-propelled disposal of bismuth in human cells
  87. Rapid labeling of intracellular His-tagged proteins in living cells
  88. Loss of APD1 in Yeast Confers Hydroxyurea Sensitivity Suppressed by Yap1p Transcription Factor
  89. Metallomic and metalloproteomic strategies in elucidating the molecular mechanisms of metallodrugs
  90. “Anion clamp” allows flexible protein to impose coordination geometry on metal ions
  91. On-line coupling of continuous-flow gel electrophoresis with inductively coupled plasma-mass spectrometry to quantitatively evaluate intracellular metal binding properties of metallochaperones HpHypA and HpHspA in E. coli cells
  92. Bio-coordination of bismuth in Helicobacter pylori revealed by immobilized metal affinity chromatography
  93. Selective interaction of Hpn-like protein with nickel, zinc and bismuth in vitro and in cells by FRET
  94. Antimony and Bismuth
  95. Structure of RPA 32 bound to the N‐terminus of SMARCAL 1 redefines the binding interface between RPA ...
  96. Urease inactivation by an unusual GroES chaperonin
  97. Functional disruption of HypB, a GTPase of Helicobacter pylori, by bismuth
  98. In-cell NMR: an emerging approach for monitoring metal-related events in living cells
  99. Size-tunable fabrication of multifunctional Bi2O3 porous nanospheres for photocatalysis, bacteria inactivation and template-synthesis
  100. Nickel translocation between metallochaperones HypA and UreE in Helicobacter pylori
  101. BiOX (X=Cl, Br, I) nanostructures: Mannitol-mediated microwave synthesis, visible light photocatalytic performance, and Cr(VI) removal capacity
  102. Identification of Metal‐Associated Proteins in Cells by Using Continuous‐Flow Gel Electrophoresis and Inductively Coupled Plasma Mass Spectrometry
  103. ChemInform Abstract: Template‐Free Fabrication of Bi2O3 and (BiO)2CO3 Nanotubes and Their Application in Water Treatment.
  104. Tunable BiOCl hierarchical nanostructures for high-efficient photocatalysis under visible light irradiation
  105. Kinetics and thermodynamics of metal binding to the N-terminus of a human copper transporter, hCTR1
  106. Binding of oxo-Cu2 clusters to ferric ion-binding protein A from Neisseria gonorrhoeae: a structural insight
  107. Histidine-rich proteins in prokaryotes: metal homeostasis and environmental habitat-related occurrence
  108. Interaction of SlyD with HypB of Helicobacter pylori facilitates nickel trafficking
  109. Structure-oriented bioinformatic approach exploring histidine-rich clusters in proteins
  110. Iron and bismuth bound human serum transferrin reveals a partially-opened conformation in the N-lobe
  111. Template‐Free Fabrication of Bi2O3 and (BiO)2CO3 Nanotubes and Their Application in Water Treatment
  112. Metallomics in environmental and health related research: Current status and perspectives
  113. Facile Microwave Synthesis of 3D Flowerlike BiOBr Nanostructures and Their Excellent CrVI Removal Capacity
  114. Recent advances in bioinorganic chemistry of bismuth
  115. Folic acid conjugated mPEG-PEI600 as an efficient non-viral vector for targeted nucleic acid delivery
  116. Covalently linking the Escherichia coli global anaerobic regulator FNR in tandem allows it to function as an oxygen stable dimer
  117. Metallo-GTPase HypB from Helicobacter pylori and Its Interaction with Nickel Chaperone Protein HypA
  118. Large-scale synthesis of bismuth hollow nanospheres for highly efficient Cr(vi) removal
  119. Activation of carboplatin and nedaplatin by the N-terminus of human copper transporter 1 (hCTR1)
  120. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1)
  121. Probing of bismuth antiulcer drug targets in H. pylori by laser ablation-inductively coupled plasma mass spectrometry
  122. Multifaceted SlyD from Helicobacter pylori: implication in [NiFe] hydrogenase maturation
  123. Microwave synthesis of BiPO4 nanostructures and their morphology-dependent photocatalytic performances
  124. Assembly of Preactivation Complex for Urease Maturation inHelicobacter pylori
  125. Histidine-rich protein Hpn from Helicobacter pylori forms amyloid-like fibrils in vitro and inhibits the proliferation of gastric epithelial AGS cells
  126. Tracking Bismuth Antiulcer Drug Uptake in Single Helicobacter pylori Cells
  127. Metal‐Binding Properties of an Hpn‐Like Histidine‐Rich Protein
  128. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  129. The Effect of the Extracellular Domain of Human Copper Transporter (hCTR1) on Cisplatin Activation
  130. NMR Studies of Metalloproteins
  131. Biological Chemistry of Arsenic, Antimony and Bismuth
  132. Biological Chemistry of Antimony and Bismuth
  133. Metalloproteomics of Arsenic, Antimony and Bismuth Based Drugs
  134. Polymeric architectures of bismuth citrate based on dimeric building blocks
  135. Online coupling of reverse-phase and hydrophilic interaction liquid chromatography for protein and glycoprotein characterization
  136. Iron-containing lipoprotein SiaA in SiaABC, the primary heme transporter of Streptococcus pyogenes
  137. Nuclear-based Metallomics in Metal-based Drugs
  138. Bismuth subcarbonate nanoparticles fabricated by water-in-oil microemulsion-assisted hydrothermal process exhibit anti-Helicobacter pylori properties
  139. A new capillary electrophoresis buffer for determining organic and inorganic anions in electroplating bath with surfactant additives
  140. A zinc-binding site by negative selection induces metallodrug susceptibility in an essential chaperonin
  141. A biomimetic zinc activated ion channel
  142. Metallomics: An integrated science for metals in biology and medicine
  143. Metallomics: An integrated biometal science
  144. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1
  145. Effect of cyclodextrin dimers with bipyridyl and biphenyl linking groups on carboxyl ester hydrolysis catalyzed by zinc complex
  146. Structure of a Nickel Chaperone, HypA, from Helicobacter pylori Reveals Two Distinct Metal Binding Sites
  147. Iron depletion decreases proliferation and induces apoptosis in a human colonic adenocarcinoma cell line, Caco2
  148. The structural and biological significance of the EAAEAE insert in the α-domain of human neuronal growth inhibitory factor
  149. Crystal Structure and Metal Binding Properties of the Lipoprotein MtsA, Responsible for Iron Transport in Streptococcus pyogenes
  150. Phosphodiester hydrolysis and specific DNA binding and cleavage promoted by guanidinium-functionalized zinc complexes
  151. Important roles of the conserved linker-KKS in human neuronal growth inhibitory factor
  152. Identification and characterization of metallodrug binding proteins by (metallo)proteomics
  153. Editorial and Advisory Board profiles
  154. Identification of Proteins Related to Nickel Homeostasis in Helicobater pylori by Immobilized Metal Affinity Chromatography and Two-Dimensional Gel Electrophoresis
  155. Study on structure–property–reactivity–function relationship of human neuronal growth inhibitory factor (hGIF)
  156. Binding of Ni2+ to a histidine- and glutamine-rich protein, Hpn-like
  157. Structure, topology and assembly of a 32-mer peptide corresponding to the loop 3 and transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  158. A Histidine-rich and Cysteine-rich Metal-binding Domain at the C Terminus of Heat Shock Protein A from Helicobacter pylori
  159. Lipoprotein MtsA of MtsABC in Streptococcus pyogenes primarily binds ferrous ion with bicarbonate as a synergistic anion
  160. Double-strand DNA cleavage by copper complexes of 2,2′-dipyridyl with guanidinium/ammonium pendants
  161. The effect of nitric oxide on metal release from metallothionein-3: gradual unfolding of the protein
  162. Biocoordination chemistry of bismuth: Recent advances
  163. Effect of α-domain substitution on the structure, property and function of human neuronal growth inhibitory factor
  164. Bismuth Complexes Inhibit the SARS Coronavirus
  165. Bismuth Complexes Inhibit the SARS Coronavirus
  166. Bioinorganic Chemistry of Bismuth and Antimony: Target Sites of Metallodrugs
  167. A proteomic approach for the identification of bismuth-binding proteins in Helicobacter pylori
  168. Solution structures, dynamics, and lipid‐binding of the sterile α‐motif domain of the deleted in liver cancer 2
  169. Structural prediction of the β-domain of metallothionein-3 by molecular dynamics simulation
  170. Metallodrugs
  171. An Effective Metallohydrolase Model with a Supramolecular Environment: Structures, Properties, and Activities
  172. Bioinorganic Chemistry of Bismuth and Antimony:  Target Sites of Metallodrugs
  173. Silver nanoparticles: partial oxidation and antibacterial activities
  174. Synthesis, Structure, and Activity of Supramolecular Mimics for the Active Site and Arg141 Residue of Copper, Zinc−Superoxide Dismutase
  175. Encapsulation of platinum anticancer drugs by apoferritin
  176. Inhibition of SARS coronavirus helicase by bismuth complexes
  177. Cleavage of double-strand DNA by zinc complexes of dicationic 2,2′-dipyridyl derivatives
  178. Flavonoid Dimers as Bivalent Modulators for Pentamidine and Sodium Stiboglucanate Resistance in Leishmania
  179. Inhibition of urease by bismuth(III): Implications for the mechanism of action of bismuth drugs
  180. Mutation at Glu23 eliminates the neuron growth inhibitory activity of human metallothionein-3
  181. Thermodynamic and Kinetic Aspects of Metal Binding to the Histidine-rich Protein, Hpn
  182. The role of Thr5 in human neuron growth inhibitory factor
  183. Proteomic Analysis of the Mode of Antibacterial Action of Silver Nanoparticles
  184. Solution structure and dynamics of human metallothionein‐3 (MT‐3)
  185. HFIP‐induced structures and assemblies of the peptides from the transmembrane domain 4 of membrane protein Nramp1
  186. Fabrication of bismuth subcarbonate nanotube arrays from bismuth citrate
  187. Expression and characterization of a histidine-rich protein, Hpn: potential for Ni 2+ storage in Helicobacter pylori
  188. Complexation of antimony (SbV) with guanosine 5′-monophosphate and guanosine 5′-diphospho-d-mannose: Formation of both mono- and bis-adducts
  189. An Insight of S-Nitrosylation of Human GIF
  190. The Stepwise Process of Chromium-Induced DNA Breakage:  Characterization by Electrochemistry, Atomic Force Microscopy, and DNA Electrophoresis
  191. Transferrin-Mediated Gold Nanoparticle Cellular Uptake
  192. 51 Sb Antimony in Medicine
  193. NMR structures and orientation of the fourth transmembrane domain of the rat divalent metal transporter (DMT1) with G185D mutation in SDS micelles
  194. Structure, Assembly, and Topology of the G185R Mutant of the Fourth Transmembrane Domain of Divalent Metal Transporter
  195. Controlled synthesis of high crystalline bismuth sulfide nanorods: using bismuth citrate as a precursor
  196. In Vitro Inhibition of Human Immunodeficiency Virus Type‐1 (HIV‐1) Reverse Transcriptase by Gold(III) Porphyrins
  197. Dynamic and Kinetic Aspects of Metallodrugs by NMR
  198. The low pKa value of iron‐binding ligand Tyr188 and its implication in iron release and anion binding of human transferrin
  199. Inhibition of alcohol dehydrogenase by bismuth☆
  200. Structure and topology of the transmembrane domain 4 of the divalent metal transporter in membrane‐mimetic environments
  201. Bismuth in Medicine
  202. DNA hydrolysis promoted by di- and multi-nuclear metal complexes
  203. The effect of the EAAEAE insert on the property of human metallothionein-3
  204. Structure of Colloidal Bismuth Subcitrate (CBS) in Dilute HCl:  Unique Assembly of Bismuth Citrate Dinuclear Units ([Bi(cit)2Bi]2-)
  205. Recognition of antimony and bismuth by peptides and proteins: insight into the mechanism of action
  206. Three dimensional structures and topology of the transmembrane domain 4 of divalent metal transporter (DMT1) in membrane-mimetic environments
  207. Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione
  208. Membrane-inserted conformation of transmembrane domain 4 of divalent-metal transporter
  209. Binding of bismuth to serum proteins: implication for targets of Bi(III) in blood plasma
  210. Gold(iii) porphyrins as a new class of anticancer drugs: cytotoxicity, DNA binding and induction of apoptosis in human cervix epitheloid cancer cellsElectronic supplementary information (ESI) available: Further experimental and crystallographic details...
  211. An oscillating C22? unit inside a copper rectangleElectronic supplementary information (ESI) available: NMR spectra and computational details. See http://www.rsc.org/suppdata/cc/b3/b301842c/
  212. Helicases as antiviral drug targets
  213. Rapid reduction of pentavalent antimony by trypanothione: potential relevance to antimonial activationElectronic supplementary information (ESI) available: experimental details. See http://www.rsc.org/suppdata/cc/b2/b210240d/
  214. Complexation of ytterbium to human transferrin and its uptake by K562 cells
  215. Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
  216. Stereo- and Enantioselective Alkene Epoxidations: A Comparative Study of D4- and D2-Symmetric Homochiral trans-Dioxoruthenium(VI) Porphyrins
  217. The role of the transferrin–transferrin-receptor system in drug delivery and targeting
  218. Interactions of Bismuth with Human Lactoferrin and Recognition of the BiIII−Lactoferrin Complex by Intestinal Cells
  219. Competitive Binding of Bismuth to Transferrin and Albumin in Aqueous Solution and in Blood Plasma
  220. Intracellular Sb-trypanothione
  221. Complexation of Antimony(III) by Trypanothione
  222. Interaction of antimony tartrate with the tripeptide glutathione
  223. TiIV Uptake and Release by Human Serum Transferrin and Recognition of TiIV-Transferrin by Cancer Cells:  Understanding the Mechanism of Action of the Anticancer Drug Titanocene Dichloride
  224. Stereoselective Formation of Seven-Coordinate Titanium(IV) Monomer and Dimer Complexes of Ethylenebis(o-hydroxyphenyl)glycine
  225. ChemInform Abstract: Transferrin as a Metal Ion Mediator
  226. Interactions of Bismuth Complexes with Metallothionein(II)
  227. Transferrin as a Metal Ion Mediator
  228. Coordination chemistry of metals in medicine: target sites for bismuth
  229. Bismuth Antiulcer Complexes
  230. N-lobe versus C-lobe complexation of bismuth by human transferrin
  231. Coordination of Zn2+ (and Cd2+) by Prokaryotic Metallothionein
  232. The First Specific TiIV-Protein Complex: Potential Relevance to Anticancer Activity of Titanocenes
  233. [1H,13C] NMR determination of the order of lobe loading of human transferrin with iron: comparison with other metal ions
  234. New approach to the solution chemistry of bismuth citrate antiulcer complexes
  235. The Biological and Medicinal Chemistry of Bismuth
  236. Determination of Bismuth in Serum Urine by Direct Injection Nebulization Inductively Coupled Plasma Mass Spectrometry
  237. Rationalisation of metal binding to transferrin: Prediction of metal-protein stability constants
  238. Rationalization of the Strength of Metal Binding to Human Serum Transferrin
  239. Molecular assemblies of diazafluorenone Schiff-base amphiphiles. III.13C NMR investigations of reversed micelles in deuteriochloroform
  240. Bismuth(III) Complexes of the Tripeptide Glutathione (γ‐L‐Glu–L‐Cys–Gly)
  241. Solid-state carbon-13 nuclear magnetic resonance investigations of bismuth citrate complexes and crystal structure of Na2[Bi2(cit)2]·7H2O
  242. 1H NMR Studies of the Imidazole Complex of Cytochrome c: Resonance Assignment and Structural Characterization of the Heme Cavity
  243. Ranitidine bismuth(III) citrate
  244. NMR Investigation of the Aggregation Behavior of Diazafluorenone Schiff Base Amphiphile in CDCL3Solution
  245. Assignments of Nonexchangeable Proton Resonances and the Solution Structures of d–TGGGT
  246. Syntheses and Characterization of Coenzyme B12 Analogues Containing 2′-Deoxynucleosede
  247. Two Dimensional1HNMR Studies on 2′5′-Dideoxyadenosylcobalamin